当前位置: X-MOL 学术Best Pract. Res. Clin. Gastroenterol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Chronic diarrhoea in an oncology patient – Clinical assessment and decision making
Best Practice & Research Clinical Gastroenterology ( IF 3.2 ) Pub Date : 2020-11-10 , DOI: 10.1016/j.bpg.2020.101708
Darren CR. Fernandes , H. Jervoise N Andreyev

Cancer survival is improving rapidly due to advances in treatments that will often involve radiotherapy, chemotherapy and novel biological agents in addition to surgery. This comes at the price of living with chronic symptoms, of which diarrhoea is particularly common. There is good evidence that for many patients these symptoms become part of everyday life, their “normality” is adjusted and symptoms are tolerated even when limiting activities severely. Clinicians often fail to appreciate the impact of these problems, as the focus of follow up tends to be on cancer recurrence. However, the rapid identification of patients in significant trouble can lead to earlier diagnosis of treatable pathologies and improvement of patients’ symptoms. The aim of this review is to highlight the mechanisms which cause oncology patients to develop diarrhoea and highlight useful investigational and treatment strategies.



中文翻译:

肿瘤科患者的慢性腹泻–临床评估和决策

由于手术的进展,癌症的生存正在迅速改善,这​​不仅包括外科手术,还包括放射疗法,化学疗法和新型生物制剂。这是以生活中慢性症状为代价的,其中腹泻尤为常见。有充分的证据表明,对于许多患者来说,这些症状已成为日常生活的一部分,即使严重限制活动量,也可以调节其“正常”状态并且可以耐受症状。由于随访的重点往往集中在癌症的复发上,因此临床医生通常无法理解这些问题的影响。但是,快速识别有严重问题的患者可以导致较早诊断出可治疗的疾病并改善患者的症状。

更新日期:2020-12-13
down
wechat
bug